Age-associated declines in skeletal muscle mass and function (sarcopenia) lead to mobility limitations, loss of independence, and adverse health outcomes.
Mitochondrial dysfunction and impaired mitochondrial quality control, particularly reduced mitophagy, are prominent features of aging muscle and are implicated in diminished bioenergetic capacity and performance.
Urolithin A (UA) is a compound made by gut bacteria from ellagitannins in foods like pomegranates, walnuts, and berries. Most people don’t produce much of it naturally, which is why it’s sold as a “postbiotic” supplement (e.g., Mitopure).
Potential benefits
Mitochondrial health/mitophagy: UA’s main proposed mechanism is stimulating mitophagy — clearing out damaged mitochondria in cells. This is well-supported in animal and cell studies.
Muscle strength/endurance: Clinical trials in middle-aged and older adults have suggested that supplementation with UA improves muscle strength and endurance. A 2026 meta-analysis specifically found improvements on the 6-minute walk test in muscle-related outcomes.
Athletic performance: A 2025 study looked at UA in highly trained distance runners, examining recovery and mitochondrial biomarkers — an active research area, not yet a settled conclusion.
Broader interest: Researchers are also studying UA in cardiovascular disease, neurodegenerative disorders, and osteoarthritis, and a newer trial is testing whether it helps preserve muscle mass during weight loss in people with obesity.
Cons / caveats
Evidence in muscle strength/mass is still mixed and preliminary — some trials show modest gains, others show little to no significant difference, especially in younger or already-healthy people.
Most positive results are in older or frail adults with more room for improvement; benefits in healthy young people are less established.
Effect sizes tend to be modest, not dramatic.
Much of the commercial marketing (creatine-adjacent “boost mitochondria” claims) outpaces the actual clinical evidence.
Long-term safety data (multi-year use) is limited since trials are mostly short-term (weeks to months).
Side effects Reported side effects across trials have generally been mild — occasional GI discomfort (nausea, diarrhea) — with no serious safety signals in the trials to date. It appears well-tolerated at studied doses (typically 500–1000 mg/day), but it’s a relatively new supplement without decades of population-level safety data.
Bottom line: reasonably promising, mechanistically interesting, but evidence is still building — strongest in older/frail adults for muscle endurance, weaker for other claimed benefits. Worth discussing with a doctor if you’re on medications or have health conditions, since I’m not able to give personalized medical advice.